Maxim Group Begins Coverage on Talphera (NASDAQ:TLPH)

Maxim Group started coverage on shares of Talphera (NASDAQ:TLPH) in a research note released on Monday morning, Benzinga reports. The brokerage issued a buy rating and a $3.00 price objective on the stock.

Separately, HC Wainwright reaffirmed a buy rating and issued a $6.00 price target on shares of Talphera in a research note on Thursday, March 7th.

Talphera Trading Up 1.0 %

Shares of NASDAQ:TLPH opened at $1.03 on Monday. The company has a market capitalization of $17.50 million, a P/E ratio of -0.70 and a beta of 0.46. Talphera has a 12 month low of $0.43 and a 12 month high of $1.61. The company’s 50-day moving average price is $1.11.

Talphera (NASDAQ:TLPH) last released its quarterly earnings results on Wednesday, March 6th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.01). The business had revenue of $0.28 million during the quarter. As a group, equities research analysts expect that Talphera will post -1.12 earnings per share for the current fiscal year.

About Talphera

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.